Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




RTS Life Sciences to Produce Robotic Blood System

By HospiMedica staff writers
Posted on 17 Apr 2006
RTS Life Sciences (Manchester, UK) has won a contract to design and install an automated robotic system incorporating machine vision for the new UK Biobank (Cheadle, UK).

The contract follows the development of a prototype vision system by the company. More...
The full fractionation system will be commissioned in the second quarter of 2006, by which time it will be fully integrated with Biobank's software and database.

The UK Biobank aims to build a major resource to support research that will improve the prevention, diagnosis, and treatment of illness and promote health throughout society. The project will follow the health of 500,000 volunteers for up to 30 years, collecting information on environment and lifestyle factors, and linking these to medical records and biologic samples.

Paul Downey, director of laboratory operations at the UK Biobank, explained that the research would require approximately 3,500 samples of blood to be processed each day. In addition to the large number of technicians this output would require, there are the serious health aspects of exposing people to such large amounts of unscreened blood.

When blood is centrifuged at low speeds, it separates into three fractions: plasma, the buffy coat containing the white blood cells, and erythrocytes. The RTS system centrifuges the blood into individual containers, identifies each sample, identifies the fractions, and aliquots the chosen fraction into arrays of 96 x1 ml tubes. A digital camera takes two images and software analyzes the images to determine the exact boundaries between the layers. The layers are then converted into liquid handling protocols and mapped to destination tubes before the robot aliquots the layers into tubes prior to storage or preparation for assays.

The UK Biobank will collect and store all fractions of blood as each fraction can reveal something different about an individual's health, and because more detailed assays will be developed in the future.



Related Links:
RTS Life Sciences
UK Biobank

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.